(Q37878507)

English

Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies.

scientific article published on September 2011

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

21605039

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21605039%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

review article

1 reference

stated in

Europe PubMed Central

title

Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

21605039

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21605039%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

0 references

1 reference

Diana L Castillo-Carranza

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

21605039

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21605039%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

author name string

C A Lasagna-Reeves

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

21605039

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21605039%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

G R Jackson

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

21605039

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21605039%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

R Kayed

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed ID

21605039

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21605039%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

publication date

1 September 2011

1 reference

stated in

Europe PubMed Central

PubMed ID

21605039

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21605039%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

published in

Current Alzheimer Research

1 reference

stated in

Europe PubMed Central

PubMed ID

21605039

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21605039%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

volume

8

1 reference

stated in

Europe PubMed Central

PubMed ID

21605039

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21605039%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

page(s)

659-665

1 reference

stated in

Europe PubMed Central

PubMed ID

21605039

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21605039%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

issue

6

1 reference

stated in

Europe PubMed Central

PubMed ID

21605039

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21605039%20AND%20SRC:MED&resulttype=core&format=json

(Q37878507)

Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)